Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 121.00B | 112.36B | 301.02B | 318.98B | 277.07B |
Gross Profit | 121.00B | 136.07B | 301.02B | 318.98B | 277.07B |
EBITDA | 23.73B | 19.85B | 13.31B | 16.45B | 20.59B |
Net Income | 8.43B | 5.37B | 4.30B | 10.95B | 10.46B |
Balance Sheet | |||||
Total Assets | 1.73T | 1.51T | 1.41T | 1.38T | 1.17T |
Cash, Cash Equivalents and Short-Term Investments | 44.39B | 42.55B | 308.46B | 293.80B | 266.36B |
Total Debt | 82.12B | 101.43B | 89.30B | 95.17B | 61.27B |
Total Liabilities | 1.61T | 1.38T | 1.31T | 1.27T | 1.05T |
Stockholders Equity | 87.07B | 78.99B | 75.51B | 88.07B | 90.65B |
Cash Flow | |||||
Free Cash Flow | 116.24B | 127.67B | 88.72B | 94.48B | 110.33B |
Operating Cash Flow | 125.95B | 134.60B | 95.02B | 98.63B | 114.20B |
Investing Cash Flow | -95.63B | -130.95B | -80.30B | -99.62B | -110.85B |
Financing Cash Flow | -27.91B | 34.99B | -9.76B | 9.06B | -945.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $1.02T | 7.15 | 7.07% | 11.71% | 37.04% | ||
78 Outperform | $746.19B | 14.60 | 16.75% | 3.72% | 7.04% | 88.41% | |
75 Outperform | HK$178.90B | 4.80 | 26.08% | 2.18% | -43.77% | ― | |
75 Outperform | $1.08T | 4.62 | 22.83% | 2.50% | 5.96% | 124.20% | |
72 Outperform | HK$54.99B | 7.40 | 9.88% | 1.96% | 17.76% | 38.31% | |
70 Outperform | $355.19B | 5.58 | 16.47% | 4.39% | 11.99% | 54.60% | |
58 Neutral | $12.54B | 5.84 | -2.71% | 5.27% | 5.88% | -56.03% |
China Taiping Insurance Holdings Company Limited has announced the merger of its nomination and remuneration committees into a single entity, the Nomination and Remuneration Committee. This strategic move is aimed at streamlining governance and enhancing the efficiency of board operations, potentially strengthening the company’s industry positioning and providing clearer oversight for stakeholders.
The most recent analyst rating on (HK:0966) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Co. has announced the merger of its nomination and remuneration committees into a single entity, the Nomination and Remuneration Committee. This strategic move is aimed at streamlining governance processes and enhancing the board’s efficiency. The committee will consist of a majority of independent non-executive directors and is tasked with reviewing the board’s structure and diversity, as well as identifying and recommending qualified candidates for board positions. This change is expected to strengthen the company’s corporate strategy and ensure a diverse and skilled board composition.
The most recent analyst rating on (HK:0966) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Co announced that all resolutions proposed at its Annual General Meeting held on May 30, 2025, were passed by shareholders. This includes the re-election of directors, approval of financial statements, declaration of a final dividend, and re-appointment of KPMG as the independent auditor. The successful passage of these resolutions reflects shareholder confidence and supports the company’s governance and operational continuity.
The most recent analyst rating on (HK:0966) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Co announced its unaudited financial figures and solvency statement for the first quarter of 2025. The announcement highlights the financial performance of its subsidiaries in China, showing a net profit of RMB 299,240,000 and total assets amounting to RMB 128,449,536. The release of these figures is in compliance with regulatory requirements and provides stakeholders with preliminary insights into the company’s financial health and operational efficiency.
China Taiping Insurance Holdings Co. announced the release of its subsidiaries’ solvency report for the first quarter of 2025. The report, which is based on unaudited preliminary financial data, highlights the company’s financial stability and compliance with the China Risk Oriented Solvency System Phase II. This disclosure is expected to reassure shareholders and potential investors about the company’s financial health and regulatory adherence.